Pioneering Pharma/IT deals target outcomes

Drugmakers are cozying up to IT companies to better make the case for their products. "This movement will be driven by a focus on outcomes," says Patrick Flochel of Ernst & Young. Novartis, for example, is working on "smart pills" that transmit data from inside the body to monitor patients' vital signs and check whether they have taken medicines as prescribed. Article